Patent · US Active

Inhibitors of TRPC6

US10800757B2 · kind B2 · utility

2Cited by

3References

28Claims

0Family size

Assignees

Boehringer Ingelheim International GmbH · DE
Hydra Biosciences, LLC · US

Inventors

Thierry Bouyssou · Mietingen, DE
Dirk Gottschling · Mittelbiberach, DE
Niklas Heine · Eberhardzell, DE
Lana Louise Smith Keenan · Poughquag, US
Michael Dennis Lowe · White Plains, US
Hossein Razavi · Danbury, US
Christopher Ronald Sarko · San Ramon, US
Simon Surprenant · Boisbriand, CA
Hidenori Takahashi · Lagrangeville, US
Michael Robert Turner · Danbury, US
Xinyuan Wu · Newton, US

Key dates

Filing date	Oct 25, 2018
Grant date	Oct 13, 2020
Priority date	—
Expiry date	Oct 25, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.